Cargando…

Gradual, but Not Sudden, Dose-Dependent Increase of ONJ Risk With Bisphosphonate Exposure: A Nationwide Cohort Study in Women With Osteoporosis

BACKGROUND: A causal relationship of bisphosphonate (BP) exposure with osteonecrosis of the jaw (ONJ) has been reported; however, a definite dose-dependent risk remains to be elucidated beyond current vague recommendations of 4-year oral BP for ONJ risk increase. OBJECTIVE: To identify the effect of...

Descripción completa

Detalles Bibliográficos
Autores principales:	Park, Jung-Hyun, Kwoen, Min-Jeong, Lee, Jae-Ryun, Kim, Keun-Suh, Lee, Hyo-Jung, Kim, Jin-Woo, Lee, Hyejin
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2021
Materias:	Endocrinology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8695600/ https://www.ncbi.nlm.nih.gov/pubmed/34956086 http://dx.doi.org/10.3389/fendo.2021.774820

Ejemplares similares

Osteonecrosis of the Jaws (ONJ) after Bisphosphonate Treatment in Patients with Multiple Myeloma: Decreasing ONJ Incidence after Adoption of Preventive Measures
por: Catania, Gioacchino, et al.
Publicado: (2016)

Effect of National Oral Health Screening Program on the Risk of Head and Neck Cancer: A Korean National Population-Based Study
por: Wee, Chan Woo, et al.
Publicado: (2022)

Case report of maxillofacial fracture in a patient under bisphosphonates in the absence of ONJ disease: Guidelines?
por: Van Camp, Philippe, et al.
Publicado: (2018)

Osteonecrosis of the Jaw (ONJ) in Osteoporosis Patients: Report of Delayed Diagnosis of a Multisite Case and Commentary about Risks Coming from a Restricted ONJ Definition
por: Migliario, Mario, et al.
Publicado: (2017)

Effect of Dosing Interval on Compliance of Osteoporosis Patients on Bisphosphonate Therapy: Observational Study Using Nationwide Insurance Claims Data
por: Lee, Hyunil, et al.
Publicado: (2021)

Increased Risk of Temporomandibular Joint Disorder in Osteoporosis Patients: A Longitudinal Study
por: Kim, So Young, et al.
Publicado: (2022)

Dose-Intensity of Bisphosphonates and the Risk of Osteonecrosis of the Jaw in Osteoporosis Patients
por: Jung, Sung-mok, et al.
Publicado: (2018)

Efficacy of local hyaluronidase administration in guided bone regeneration surgery: a randomized controlled trial
por: Kwoen, Min-Jeong, et al.
Publicado: (2021)

Augmentation of IFN-γ by bone marrow derived immune cells in the presence of severe suppression of IFN-γ in gingivae induced by zoledronic acid and denosumab in Hu-BLT mice model of ONJ
por: Kaur, Kawaljit, et al.
Publicado: (2023)

Can Alarming Improve Compliance with Weekly Bisphosphonate in Patients with Osteoporosis?
por: Nho, Jae-Hwi, et al.
Publicado: (2016)

Bisphosphonate-related osteonecrosis of the jaw in a patient with osteoporosis following treatment of testicular cancer: a case report
por: Kim, Do-Sup, et al.
Publicado: (2015)

Mitigating osteonecrosis of the jaw (ONJ) through preventive dental care and understanding of risk factors
por: Wan, Jason T., et al.
Publicado: (2020)

The effect of low-dose intravenous bisphosphonate treatment on osteoporosis in children with quadriplegic cerebral palsy
por: Moon, Soon Jeong, et al.
Publicado: (2017)

Four-Year Teriparatide Followed by Denosumab vs. Continuous Denosumab in Glucocorticoid-Induced Osteoporosis Patients With Prior Bisphosphonate Treatment
por: Hirooka, Yasuaki, et al.
Publicado: (2021)

Effect of Lumbar Spinal Stenosis on Treatment of Osteoporosis: Comparison of Three Oral Bisphosphonate Therapies
por: Park, Hyung-Youl, et al.
Publicado: (2023)

Differential Effect of Metabolic Health and Obesity on Incident Heart Failure: A Nationwide Population-Based Cohort Study
por: Kim, Hwi Seung, et al.
Publicado: (2021)

Gradually Then Suddenly? Decline in Vision-Related Quality of Life as Glaucoma Worsens
por: Jones, Lee, et al.
Publicado: (2017)

Better oral hygiene is associated with a reduced risk of osteoporotic fracture: a nationwide cohort study
por: Park, Jung-Hyun, et al.
Publicado: (2023)

Efficacy and tolerability of medical ozone gas insufflations in patients with osteonecrosis of the jaw treated with bisphosphonates—Preliminary data(): Medical ozone gas insufflation in treating ONJ lesions
por: Ripamonti, C.I., et al.
Publicado: (2012)

Position Statement: Drug Holiday in Osteoporosis Treatment with Bisphosphonates in South Korea
por: Lee, Seung Hun, et al.
Publicado: (2015)

Oral Treatment With Bisphosphonates of Osteoporosis Does Not Increase the Risk of Severe Gastrointestinal Side Effects: A Meta-Analysis of Randomized Controlled Trials
por: Dömötör, Zsuzsa Réka, et al.
Publicado: (2020)

Implications of metabolic health status and obesity on the risk of kidney cancer: A nationwide population-based cohort study
por: Cho, Yun Kyung, et al.
Publicado: (2022)

Power of universal health coverage in the era of COVID-19: A nationwide observational study
por: Lee, Hyejin, et al.
Publicado: (2021)

Role of Bisphosphonates in Postmenopausal Women with Osteoporosis to Prevent Future Fractures: A Literature Review
por: Imam, Bashir, et al.
Publicado: (2019)

Intravenous bisphosphonates for postmenopausal osteoporosis
por: Mottaghi, Peyman
Publicado: (2010)

Bisphosphonates adherence for treatment of osteoporosis
por: Vieira, Helena Parente, et al.
Publicado: (2013)

Compliance and persistence with oral bisphosphonates for the treatment of osteoporosis in female patients with rheumatoid arthritis
por: Park, Ji-Heh, et al.
Publicado: (2017)

Optimizing dosing frequencies for bisphosphonates in the management of postmenopausal osteoporosis: patient considerations
por: Sunyecz, John
Publicado: (2008)

Piezo-electric surgery use for the management of patients with onj drug-induced: our experience
por: Cristofaro, M G, et al.
Publicado: (2010)

Determination of the molecular mechanism by which macrophages and γδ-T cells contribute to ZOL-induced ONJ
por: Qu, Xingzhou, et al.
Publicado: (2020)

Unravelling the Inflammatory Processes in the Early Stages of Diabetic Nephropathy and the Potential Effect of (S(s))-DS-ONJ
por: Gómez-Jaramillo, Laura, et al.
Publicado: (2022)

Combination therapy of anabolic agents and bisphosphonates on bone mineral density in patients with osteoporosis: a meta-analysis of randomised controlled trials
por: Lou, Shenghan, et al.
Publicado: (2018)

Atypical Femoral Fracture Combined with Osteonecrosis of Jaw During Osteoporosis Treatment with Bisphosphonate
por: Won, Yougun, et al.
Publicado: (2014)

Interactive Associations between PPARγ and PPARGC1A and Bisphosphonate-Related Osteonecrosis of the Jaw in Patients with Osteoporosis
por: Kim, Jung Sun, et al.
Publicado: (2023)

Nationwide changes in physical activity, nutrient intake, and obesity in South Korea during the COVID-19 pandemic era
por: Yang, Hong Jun, et al.
Publicado: (2022)

A reappraisal of generic bisphosphonates in osteoporosis
por: Kanis, J. A., et al.
Publicado: (2011)

Bisphosphonates and glucocorticoid-induced osteoporosis: cons
por: Lems, Willem F., et al.
Publicado: (2015)

Long-term use of bisphosphonates in osteoporosis
por: Sadat-Ali, Mir, et al.
Publicado: (2017)

Long-term use of bisphosphonates in osteoporosis
por: Alwahhabi, Basmah K., et al.
Publicado: (2017)

Association between changes in predicted body composition and occurrence of heart failure: a nationwide population study
por: Woo, Ho Geol, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_6auhumrt919q76cekbi3e1k4cc